Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Enhanced charge density wave coherence in a light-quenched, high-temperature superconductor.

Science (New York, N.Y.)·2022
Same author

Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery.

ESMO open·2021
Same author

Impact of the COVID -19 pandemic on the organisation of breast reconstruction in France.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2020
Same author

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials.

BMC medical informatics and decision making·2020
Same author

Correction to: <sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumors.

European journal of nuclear medicine and molecular imaging·2019

Related Experiment Video

Updated: Jun 4, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Dose-finding approach for dose escalation with overdose control considering incomplete observations.

A Mauguen1, M C Le Deley, S Zohar

  • 1Service de Biostatistique et d'Epidémiologie, Institut Gustave Roussy, Villejuif, France. audrey.mauguen@igr.fr

Statistics in Medicine
|February 26, 2011
PubMed
Summary

The new time-to-event dose-escalation with overdose control (TITE-EWOC) method significantly reduces trial duration. This innovative approach maintains excellent overdose control and accurately identifies the maximum tolerated dose without compromising patient safety.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Pharmacology

Background:

  • Traditional dose-finding trials can be lengthy and may not efficiently control for overdosing.
  • The Escalation With Overdose Control (EWOC) method by Babb et al. offers improved overdose control.
  • Integrating time-to-event data can potentially accelerate clinical trial processes.

Purpose of the Study:

  • To introduce a novel hybrid design, the time-to-event dose-escalation method with overdose control (TITE-EWOC).
  • To assess if TITE-EWOC can decrease dose-finding trial duration while preserving EWOC's overdose control capabilities.
  • To evaluate the performance of TITE-EWOC against the standard EWOC method.

Main Methods:

  • A simulation study was conducted to compare TITE-EWOC with the EWOC method.
  • Four distinct dose-toxicity relationships were explored.
  • Three different mean inter-patient arrival times were simulated to assess timing impacts.

Main Results:

  • TITE-EWOC significantly decreased trial duration across most simulated scenarios.
  • The proportion of overdosed patients and dose-limiting toxicities remained comparable to EWOC.
  • Performance was consistent across dose-toxicity relationships, except for very short patient arrival times.

Conclusions:

  • The TITE-EWOC design offers a substantial reduction in clinical trial duration.
  • This method effectively maintains overdose control and minimizes dose-limiting toxicities.
  • TITE-EWOC retains the ability to accurately identify the maximum tolerated dose, enhancing trial efficiency.